NR
Nurix Ther
NRIX·NASDAQSan Francisco CAFounded 2009200 employees
Small CapbiotechPublicOncologyImmunology
Platform: E3 Lig Degrader
Market Cap
$0.6B
All Drugs
2
Clinical Trials
2
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (NRIX)
Loading NRIX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemaratamab | NRI-2198 | Phase 1/2 | 1 | PARP | AMLDLBCL | ||
| Teralemzoparlimab | NRI-2737 | Phase 2/3 | 1 | AuroraA | LNMDS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)